Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
biote Corp. stock logo
BTMD
biote
$5.58
-0.2%
$5.77
$3.65
$8.22
$415.88M0.87107,617 shs42,029 shs
ChromaDex Co. stock logo
CDXC
ChromaDex
$3.39
-0.3%
$2.81
$1.25
$4.65
$255.30M1.99263,009 shs193,155 shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
MariMed Inc. stock logo
MRMD
MariMed
$0.27
+3.9%
$0.26
$0.20
$0.55
$100.24M2.85457,623 shs126,577 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
biote Corp. stock logo
BTMD
biote
+0.36%+1.27%-7.14%+44.44%-6.83%
ChromaDex Co. stock logo
CDXC
ChromaDex
0.00%-14.36%-10.29%+131.29%+153.73%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%-37.72%
MariMed Inc. stock logo
MRMD
MariMed
+0.31%-3.92%-4.74%-21.71%-31.44%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
biote Corp. stock logo
BTMD
biote
1.7835 of 5 stars
3.52.00.00.00.00.81.9
ChromaDex Co. stock logo
CDXC
ChromaDex
3.631 of 5 stars
3.52.00.04.11.80.80.6
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
MariMed Inc. stock logo
MRMD
MariMed
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
biote Corp. stock logo
BTMD
biote
3.00
Buy$8.1145.34% Upside
ChromaDex Co. stock logo
CDXC
ChromaDex
3.00
Buy$5.8773.06% Upside
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/A
MariMed Inc. stock logo
MRMD
MariMed
N/AN/AN/AN/A

Current Analyst Ratings

Latest CDXC, BTMD, HEXO, and MRMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
ChromaDex Co. stock logo
CDXC
ChromaDex
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.25 ➝ $6.00
3/13/2024
biote Corp. stock logo
BTMD
biote
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00 ➝ $9.00
2/20/2024
biote Corp. stock logo
BTMD
biote
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
2/1/2024
biote Corp. stock logo
BTMD
biote
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.55
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
biote Corp. stock logo
BTMD
biote
$185.36M2.24$0.50 per share11.19($0.58) per share-9.62
ChromaDex Co. stock logo
CDXC
ChromaDex
$83.57M3.05N/AN/A$0.38 per share8.92
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
MariMed Inc. stock logo
MRMD
MariMed
$148.60M0.67$0.03 per share8.92$0.19 per share1.41

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
biote Corp. stock logo
BTMD
biote
$3.32M-$0.22N/A9.30N/A1.79%-45.10%19.61%5/7/2024 (Confirmed)
ChromaDex Co. stock logo
CDXC
ChromaDex
-$4.94M-$0.07N/A56.50N/A-5.91%-17.81%-9.17%5/8/2024 (Confirmed)
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
MariMed Inc. stock logo
MRMD
MariMed
-$16.03M-$0.04N/AN/A-10.79%-1.84%-0.72%N/A

Latest CDXC, BTMD, HEXO, and MRMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
ChromaDex Co. stock logo
CDXC
ChromaDex
-$0.03N/A+$0.03N/AN/AN/A
5/7/2024N/A
biote Corp. stock logo
BTMD
biote
$0.05N/A-$0.05N/AN/AN/A  
3/12/2024Q4 2023
biote Corp. stock logo
BTMD
biote
$0.08$0.14+$0.06$0.10$45.50 million$45.70 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
biote Corp. stock logo
BTMD
biote
N/AN/AN/AN/AN/A
ChromaDex Co. stock logo
CDXC
ChromaDex
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
MariMed Inc. stock logo
MRMD
MariMed
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
biote Corp. stock logo
BTMD
biote
N/A
5.51
4.73
ChromaDex Co. stock logo
CDXC
ChromaDex
N/A
2.40
1.70
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
MariMed Inc. stock logo
MRMD
MariMed
0.97
1.67
0.85

Ownership

Institutional Ownership

CompanyInstitutional Ownership
biote Corp. stock logo
BTMD
biote
21.68%
ChromaDex Co. stock logo
CDXC
ChromaDex
15.41%
HEXO Corp. stock logo
HEXO
HEXO
7.78%
MariMed Inc. stock logo
MRMD
MariMed
0.18%

Insider Ownership

CompanyInsider Ownership
biote Corp. stock logo
BTMD
biote
13.90%
ChromaDex Co. stock logo
CDXC
ChromaDex
10.57%
HEXO Corp. stock logo
HEXO
HEXO
4.69%
MariMed Inc. stock logo
MRMD
MariMed
20.55%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
biote Corp. stock logo
BTMD
biote
19474.53 million64.17 millionNot Optionable
ChromaDex Co. stock logo
CDXC
ChromaDex
10675.31 million67.35 millionOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
MariMed Inc. stock logo
MRMD
MariMed
643375.13 million298.04 millionNot Optionable

CDXC, BTMD, HEXO, and MRMD Headlines

SourceHeadline
Cannabis Investors Share Chips Make Chunks Wisdom For Business Expansion At Benzinga ConferenceCannabis Investors Share 'Chips Make Chunks' Wisdom For Business Expansion At Benzinga Conference
msn.com - April 21 at 3:24 PM
A F—ed-Up Situation, Says MariMed CCO About How State Regulations Complicate Cannabis Edibles Strategy'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles Strategy
benzinga.com - April 17 at 9:16 PM
Critical Review: MariMed (OTCMKTS:MRMD) versus Cronos Group (NASDAQ:CRON)Critical Review: MariMed (OTCMKTS:MRMD) versus Cronos Group (NASDAQ:CRON)
americanbankingnews.com - April 16 at 4:24 AM
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Companys Fifth Illinois DispensaryMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary
uk.investing.com - April 13 at 9:31 PM
3 Marijuana Stocks To Add To Your Watchlist This Week3 Marijuana Stocks To Add To Your Watchlist This Week
marijuanastocks.com - April 13 at 9:00 AM
MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis DispensaryMariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary
msn.com - April 11 at 4:07 PM
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
finance.yahoo.com - April 11 at 9:25 AM
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
finance.yahoo.com - April 11 at 9:25 AM
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Companys Fifth Illinois DispensaryMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary
globenewswire.com - April 11 at 7:30 AM
Mass. cannabis firm sponsors MGM Music Hall, House of BluesMass. cannabis firm sponsors MGM Music Hall, House of Blues
bizjournals.com - April 10 at 2:09 PM
MariMed Partners with Iconic Boston Music VenuesMariMed Partners with Iconic Boston Music Venues
globenewswire.com - April 10 at 7:30 AM
MariMed Partners with Iconic Boston Music VenuesMariMed Partners with Iconic Boston Music Venues
globenewswire.com - April 10 at 7:30 AM
MariMed Inc.: MariMed Closes Acquisition of Second Maryland DispensaryMariMed Inc.: MariMed Closes Acquisition of Second Maryland Dispensary
finanznachrichten.de - April 9 at 12:20 PM
MariMed Closes Acquisition of Second Maryland DispensaryMariMed Closes Acquisition of Second Maryland Dispensary
globenewswire.com - April 9 at 7:30 AM
MariMed Announces First Quarter 2024 Earnings DateMariMed Announces First Quarter 2024 Earnings Date
globenewswire.com - April 8 at 7:30 AM
Unsexy Alternative, Operating Within Constraints, Consistency & Love: 3 Experts On Making Cannabis Businesses Self-Sustainable'Unsexy' Alternative, Operating Within Constraints, Consistency & Love: 3 Experts On Making Cannabis Businesses Self-Sustainable
msn.com - March 27 at 8:06 PM
A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, IllinoisA Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois
globenewswire.com - March 12 at 7:30 AM
MariMed Inc. (MRMD) Q4 2023 Earnings Call TranscriptMariMed Inc. (MRMD) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 9 at 1:17 PM
MariMed Inc. (PNK:MRMD) Q4 2023 Earnings Call TranscriptMariMed Inc. (PNK:MRMD) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 8 at 8:27 PM
MariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2023 EarningsMariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2023 Earnings
finanznachrichten.de - March 8 at 12:01 AM
MariMed Reports Another Year Of Strong Operational And Financial Performance And More To Come In 2024MariMed Reports 'Another Year Of Strong Operational And Financial Performance' And More To Come In 2024
msn.com - March 7 at 12:46 AM
MRMD Stock Earnings: MariMed Beats Revenue for Q4 2023MRMD Stock Earnings: MariMed Beats Revenue for Q4 2023
investorplace.com - March 7 at 12:02 AM
MariMeds Earnings: A PreviewMariMed's Earnings: A Preview
benzinga.com - March 6 at 7:46 PM
MariMed Reports Fourth Quarter and Full Year 2023 EarningsMariMed Reports Fourth Quarter and Full Year 2023 Earnings
globenewswire.com - March 6 at 5:01 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

biote logo

biote

NASDAQ:BTMD
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
ChromaDex logo

ChromaDex

NASDAQ:CDXC
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
HEXO logo

HEXO

NYSE:HEXO
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.
MariMed logo

MariMed

OTCMKTS:MRMD
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.